Add one more name to the new slew of
pharma companies trying to counteract the public backlash to big drug price increases: France's Sanofi, a $ 126 billion firm known for its flagship diabetes and vaccines units.
Not exact matches
«These findings could allow the
pharma companies to open up large libraries of potent drug candidates earlier discarded due to solubility problems and
try them again together with Upsalite,» says Maria Strømme, Professor at the Division of Nanotechnology and Functional Materials at Uppsala University.
At the same time that Purdue and other big
pharma companies were hosting symposia, they doubled their sales force and gave doctors 30 - day free coupons so they could let patients
try these drugs for pain that previously wasn't managed using opiates.
Years ago, the model was that big
pharma companies located in New Jersey, or Pennsylvania or New York; they would have their own research campus
try to discover therapies and go through the clinic with them, and eventually a drug would occur.